The metabolic syndrome in patients on peritoneal dialysis: Prevalence and influence on cardiovascular morbidity

Bosnian Journal of Basic Medical Sciences

Volumn 10, Issue SUPPL. 1, 2010, Pages

  Rašić, Senija ^a   Hadžović Džuvo, Almira ^a   Rebić, Damir ^a   Uncanin, Snežana ^a   Hadžić, Azra ^a   Mujaković, Aida ^a   Kulenović, Indira ^b  

^a UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

^b Medical Departement   (Bosnia and Herzegovina)

Author keywords

Cardiovascular morbidity; Metabolic syndrome; Peritoneal dialysis

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PREVALENCE; RISK FACTOR; TREATMENT OUTCOME; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2;

ADULT; AGED; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREVALENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 77953270161     PISSN: 15128601     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Wilkin T. J., Voss L. D. Metabolic syndrome: Maladaptation to a modern world. J. R. Soc. Med. 2004;97(11):511-520.
2. Grundy S. M. Metabolic syndrome pandemic. Arterioscler. Thromb. Vasc. Biol. 2008;86:629-636.
3. Malik S., Wong N. D. Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis. Expert Res. Cardiovasc. Trier. 2009;7(3) 272-280.
4. Li P. K.-T., Kwan B. C.-H., Szeto C. C., Ko G. T.-C. Metabolic syndrome in peritoneal dialysis patients. Nephrol. Dial. Transplant. 2008;1(4):206-214.
5. McDonald S. P., Collins J. F., Johnsson D. W. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand Patients populations. J. Am. Soc. Nephrol. 2003;14:2894-2901.
6. Peterson G. E., de Backer T., Gabriel A., Ilic V., Vagaonescu T., Appel L. J., Contreras G., Kendrick C., Rostand S., Phillips R. A.; African American Study of Kidney Disease Investigators. Prevalence and correlates of left ventricular hypertrophy in the African American Study of Kidney Disease Cohort Study. Hypertension. 2007;50:1033-1039
7. Bestermann W., Houston M. C., Basile J., Egan B., Ferrario C. M., Lackland D., Hawkins R. G., Reed J., Rogers P., Wise D., Moore M. A. Addressing the global cardiovascular risk of hypertensive, dislipidemia, diabetes mellitus and the metabolic syndrome in the southeastern United States. Am. J. Med. Sci. 2005;329:292-305.
8. Park S. H., Lindholm B. Definition of metabolic syndrome in peritoneal dialysis. Perit. Dial Int., 2009;29(Suppl 2) : S137-S144
9. Eckel R. H., Grundy S. M., Zimmet P. Z. The metabolic syndrome. Lancet. 2005;365:1415-1428.
10. Morrison G. Metabolic effects of continuous ambulatory peritoneal dialysis. Ann. Rev. Med. 1989;40:163-172.
11. Li P. K., Chow K. M. The clinical and epidemiological aspects of vascular mortality in chronic peritoneal dialysis patients. Perit. Dial. Int. 2005;25(Suppl 3) : S112-S119.
12. Johnson D. W., Armstrong K., Campbell S. B., Mudge D. W., Hawley C. M., Coombes J. S., Prins J. B., Isbel N. M. Metabolic syndrome in severe chronic kidney disease: prevalence, predictors, prognostic significance and effects of risk factors modification. Nephrology (Carlton). 2007;12:391-398.
13. Holmes C. J., Shockley T. R. Strategies to reduce glucose exposure in peritoneal dialysis patients. Perit. Dial. Int. 2000;20(Suppl 2) : S37-S41.
14. Young D. O., Lund R. J., Haynatzki G., Dunlay R. W. Prevalence of the metabolic syndrome in an incident dialysis population. Hemodial. Int. 2007;11:86-95.
15. Kwan B. C., Szeto C., Ckow K., Leung C., Li P. K. Metabolic syndrome and cardiovascular mortality in Chinese PD patients. Abstracts from the 12th Congress of the International Society for Peritoneal Dialysis, Istanbul 2008; In: Peritoneal Dialysis International. 2008;28(Suppl 4) : 560.
16. Lindsay R. S., Howard B. V. Cardiovascular risk associated with the metabolic syndrome. Curr. Diab. Rep. 2004: 463-68.
17. Dekker J. M., Girman C., Rhodes T., Nijpels G., Stehouher C. D., Bouter L. M., Heine R. J. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation. 2005;112:666-673.
18. Chinali M., Devereux R. B., Howard B. V., Roman M. J., Bella J. N., Liu J. E., Resnick H. E., Lee E. T., Best L. G., de Simone G. Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Am. J. Cardiol. 2004;93:40-41.